Alternatives to Cellink (now part of BICO)

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered drug discovery and development platform for biologics.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Advance every cancer decision.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.